Type 1 interferons contribute to the clearance of senescent cell

Cancer Biology and Therapy

Volumn 16, Issue 8, 2015, Pages 1214-1219

  Katlinskaya, Yuliya V ^a   Carbone, Christopher J ^a   Yu, Qiujing ^a   Fuchs, Serge Y ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Interferon; NK cells; Senescence; Senescent cell clearance

Indexed keywords

BETA GALACTOSIDASE; INTERFERON; INTERFERON RECEPTOR; MESSENGER RNA; MICA PROTEIN; MICB PROTEIN; NATURAL KILLER CELL RECEPTOR NKG2D; ULBP2 PROTEIN; UNCLASSIFIED DRUG; ALPHA BETA INTERFERON RECEPTOR; BETA INTERFERON; GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORED PROTEIN; HLA ANTIGEN CLASS 1; IFNAR1 PROTEIN, MOUSE; KLRK1 PROTEIN, HUMAN; MHC CLASS I-RELATED CHAIN A; NATURAL KILLER CELL LECTIN LIKE RECEPTOR SUBFAMILY K; SIGNAL PEPTIDE; ULBP2 PROTEIN, HUMAN;

ANIMAL CELL; ARTICLE; CELL AGING; CELL DAMAGE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; EMBRYO; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NATURAL KILLER CELL; NONHUMAN; PROTEIN EXPRESSION; SENESCENCE; ANIMAL; C57BL MOUSE; CELL CULTURE; DRUG EFFECTS; FIBROBLAST; GENETICS; IMMUNOLOGY; METABOLISM; MUTANT MOUSE STRAIN; PATHOLOGY; PHYSIOLOGY; PROGERIA; WERNER SYNDROME;

ANIMALS; CELL AGING; CELLS, CULTURED; FIBROBLASTS; GPI-LINKED PROTEINS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; INTERFERON TYPE I; INTERFERON-BETA; MICE, INBRED C57BL; MICE, MUTANT STRAINS; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY K; PROGERIA; RECEPTOR, INTERFERON ALPHA-BETA; WERNER SYNDROME;

EID: 84983389376     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.1080/15384047.2015.1056419     Document Type: Article

References (38)

1. Lindahl T, Wood RD. Quality control by DNA repair. Science 1999; 286:1897-905; PMID:10583946; http://dx.doi.org/10.1126/science.286.5446.1897
2. Hasty P, Campisi J, Hoeijmakers J, van Steeg H, Vijg J. Aging and genome maintenance: lessons from the mouse? Science 2003; 299:1355-9; PMID:12610296; http://dx.doi.org/10.1126/science.1079161
3. Weitzman MD, Lilley CE, Chaurushiya MS. Genomes in conflict: maintaining genome integrity during virus infection. Ann Rev Microbiol 2010; 64:61-81; PMID:20690823; http://dx.doi.org/10.1146/annurev.micro.112408.134016
4. Katze MG, He Y, Gale M Jr.. Viruses and interferon: a fight for supremacy. Nat Rev Immunol 2002; 2:675-87; PMID:12209136; http://dx.doi.org/10.1038/nri888
5. Yu Q, Carbone CJ, Katlinskaya YV, Zheng H, Zheng K, Luo M, Wang PJ, Greenberg RA, Fuchs SY. Type I interferon controls propagation of long interspersed element-1. J Biol Chem 2015; 290:10191-9; PMID:25716322; http://dx.doi.org/10.1074/jbc.M114.612374
6. Yu Q, Katlinskaya YV, Carbone CJ, Zhao B, Katlinski KV, Zheng H, Guha M, Li N, Chen Q, Yang T, et al. DNA-damage-induced type I interferon promotes senescence and inhibits stem cell function. Cell Rep 2015; 11:785-97; PMID:25921537; http://dx.doi.org/10.1016/j.celrep.2015.03.069
7. van Deursen JM. The role of senescent cells in ageing. Nature 2014; 509:439-46; PMID:24848057; http://dx.doi.org/10.1038/nature13193
8. Campisi J. Senescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors. Cell 2005; 120:513-22; PMID:15734683; http://dx.doi.org/10.1016/j.cell.2005.02.003
9. Raulet DH, Guerra N. Oncogenic stress sensed by the immune system: role of natural killer cell receptors. Nat Rev Immunol 2009; 9:568-80; PMID:19629084; http://dx.doi.org/10.1038/nri2604
10. Sagiv A, Biran A, Yon M, Simon J, Lowe SW, Krizhanovsky V. Granule exocytosis mediates immune surveillance of senescent cells. Oncogene 2013; 32:1971-7; PMID:22751116; http://dx.doi.org/10.1038/onc.2012.206
11. Krizhanovsky V, Yon M, Dickins RA, Hearn S, Simon J, Miething C, Yee H, Zender L, Lowe SW. Senescence of activated stellate cells limits liver fibrosis. Cell 2008; 134:657-67; PMID:18724938; http://dx.doi.org/10.1016/j.cell.2008.06.049
12. Xue W, Zender L, Miething C, Dickins RA, Hernando E, Krizhanovsky V, Cordon-Cardo C, Lowe SW. Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas. Nature 2007; 445:656-60; PMID:17251933; http://dx.doi.org/10.1038/nature05529
13. Gasser S, Orsulic S, Brown EJ, Raulet DH. The DNA damage pathway regulates innate immune system ligands of the NKG2D receptor. Nature 2005; 436:1186-90; PMID:15995699; http://dx.doi.org/10.1038/nature03884
14. Munoz-Espin D, Serrano M. Cellular senescence: from physiology to pathology. Nat Rev Mol Cell Biol 2014; 15:482-96; PMID:24954210; http://dx.doi.org/10.1038/nrm3823
15. Acosta JC, Banito A, Wuestefeld T, Georgilis A, Janich P, Morton JP, Athineos D, Kang TW, Lasitschka F, Andrulis M, et al. A complex secretory program orchestrated by the inflammasome controls paracrine senescence. Nat Cell Biol 2013; 15:978-90; PMID:23770676; http://dx.doi.org/10.1038/ncb2784
16. Mukherjee AB, Costello C. Aneuploidy analysis in fibroblasts of human premature aging syndromes by FISH during in vitro cellular aging. Mech Ageing Dev 1998; 103:209-22; PMID:9701772; http://dx.doi.org/10.1016/S0047-6374(98)00041-4
17. Goldstein S, Wojtyk RI, Harley CB, Pollard JW, Chamberlain JW, Stanners CP. Protein synthetic fidelity in aging human fibroblasts. Adv Exp Med Biol 1985; 190:495-508; PMID:4083161
18. Harley CB, Pollard JW, Chamberlain JW, Stanners CP, Goldstein S. Protein synthetic errors do not increase during aging of cultured human fibroblasts. Proc Natl Acad Sci U S A 1980; 77:1885-9; PMID:6246512; http://dx.doi.org/10.1073/pnas.77.4.1885
19. Moiseeva O, Mallette FA, Mukhopadhyay UK, Moores A, Ferbeyre G. DNA damage signaling and p53-dependent senescence after prolonged beta-interferon stimulation. Mol Biol Cell 2006; 17:1583-92; PMID:16436515; http://dx.doi.org/10.1091/mbc.E05-09-0858
20. Ovadya Y, Krizhanovsky V. Senescent cells: SASPected drivers of age-related pathologies. Biogerontology 2014; 15:627-42; PMID:25217383; http://dx.doi.org/10.1007/s10522-014-9529-9
21. Burton DG, Krizhanovsky V. Physiological and pathological consequences of cellular senescence. Cell Mol Life Sci: CMLS 2014; 71:4373-86; PMID:25080110; http://dx.doi.org/10.1007/s00018-014-1691-3
22. Iannello A, Raulet DH. Immune surveillance of unhealthy cells by natural killer cells. Cold Spring Harbor Symp Quant Biol 2013; 78:249-57; PMID:24135717; http://dx.doi.org/10.1101/sqb.2013.78.020255
23. Sagiv A, Krizhanovsky V. Immunosurveillance of senescent cells: the bright side of the senescence program. Biogerontology 2013; 14:617-28; PMID:24114507; http://dx.doi.org/10.1007/s10522-013-9473-0
24. Hazeldine J, Lord JM. The impact of ageing on natural killer cell function and potential consequences for health in older adults. Ageing Res Rev 2013; 12:1069-78; PMID:23660515; http://dx.doi.org/10.1016/j.arr.2013.04.003
25. Le Page C, Genin P, Baines MG, Hiscott J. Interferon activation and innate immunity. Rev Immunogenet 2000; 2:374-86; PMID:11256746
26. Fuchs SY. Hope and fear for interferon: the receptor-centric outlook on the future of interferon therapy. J Interferon Cytokine Res: Off J Int Soc Interferon Cytokine Res 2013; 33:211-25; PMID:23570388; http://dx.doi.org/10.1089/jir.2012.0117
27. Carbone CJ, Zheng H, Bhattacharya S, Lewis JR, Reiter AM, Henthorn P, Zhang ZY, Baker DP, Ukkira-mapandian R, Bence KK, et al. Protein tyrosine phosphatase 1B is a key regulator of IFNAR1 endocytosis and a target for antiviral therapies. Proc Natl Acad Sci USA 2012;109:19226-31;PMID:23129613; http://dx.doi.org/10.1073/pnas.1211491109
28. Bhattacharya S, HuangFu WC, Dong G, Qian J, Baker DP, Karar J, Koumenis C, Diehl JA, Fuchs SY. Anti-tumorigenic effects of Type 1 interferon are subdued by integrated stress responses. Oncogene 2013; 32:4214-21; PMID:23045272; http://dx.doi.org/10.1038/onc.2012.439
29. Bhattacharya S, Qian J, Tzimas C, Baker DP, Koumenis C, Diehl JA, Fuchs SY. Role of p38 protein kinase in the ligand-independent ubiquitination and down-regulation of the IFNAR1 chain of type I interferon receptor. J Biol Chem 2011; 286:22069-76; PMID:21540188; http://dx.doi.org/10.1074/jbc.M111.238766
30. Bhattacharya S, HuangFu WC, Liu J, Veeranki S, Baker DP, Koumenis C, Diehl JA, Fuchs SY. Inducible priming phosphorylation promotes ligand-independent degradation of the IFNAR1 chain of type I interferon receptor. J Biol Chem 2010; 285:2318-25; PMID:19948722; http://dx.doi.org/10.1074/jbc.M109.071498
31. Liu J, Carvalho LP, Bhattacharya S, Carbone CJ, Kumar KG, Leu NA, Yau PM, Donald RG, Weiss MJ, Baker DP, et al. Mammalian casein kinase 1alpha and its leishmanial ortholog regulate stability of IFNAR1 and type I interferon signaling. Mol Cell Biol 2009; 29:6401-12; PMID:19805514; http://dx.doi.org/10.1128/MCB.00478-09
32. Platanias LC. Mechanisms of type-I- and type-II-interferon-mediated signalling. Nat Rev Immunol 2005; 5:375-86; PMID:15864272; http://dx.doi.org/10.1038/nri1604
33. Takaoka A, Hayakawa S, Yanai H, Stoiber D, Negishi H, Kikuchi H, Sasaki S, Imai K, Shibue T, Honda K, et al. Integration of interferon-alpha/beta signalling to p53 responses in tumour suppression and antiviral defence. Nature 2003; 424:516-23; PMID:12872134; http://dx.doi.org/10.1038/nature01850
34. Iannello A, Thompson TW, Ardolino M, Lowe SW, Raulet DH. p53-dependent chemokine production by senescent tumor cells supports NKG2D-dependent tumor elimination by natural killer cells. J Exp Med 2013; 210:2057-69; PMID:24043758; http://dx.doi.org/10.1084/jem.20130783
35. Baker DJ, Wijshake T, Tchkonia T, LeBrasseur NK, Childs BG, van de Sluis B, Kirkland JL, van Deursen JM. Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders. Nature 2011; 479:232-6; PMID:22048312; http://dx.doi.org/10.1038/nature10600
36. Huangfu WC, Qian J, Liu C, Liu J, Lokshin AE, Baker DP, Rui H, Fuchs SY. Inflammatory signaling compromises cell responses to interferon alpha. Oncogene 2012; 31:161-72; PMID:21666722; http://dx.doi.org/10.1038/onc.2011.221
37. Zheng H, Qian J, Carbone CJ, Leu NA, Baker DP, Fuchs SY. Vascular endothelial growth factor-induced elimination of the type 1 interferon receptor is required for efficient angiogenesis. Blood 2011; 118:4003-6; PMID:21832278; http://dx.doi.org/10.1182/blood-2011-06-359745
38. Zheng H, Qian J, Varghese B, Baker DP, Fuchs S. Ligand-stimulated downregulation of the alpha interferon receptor: role of protein kinase D2. Mol Cell Biol 2011; 31:710-20; PMID:21173164; http://dx.doi.org/10.1128/MCB.01154-10